Recombinant SARS-CoV-2 antigens for development and validation of diagnostic tests. Supports COVID-19 testing kit development and quality assurance.
Manufactured by
Wuhan Fine Biotech Co., Ltd.
Wuhan, China
Specializes in manufacturing ELISA kits, antibodies, proteins and relevant reagents for immunoassay testing applications. The ISO 9001:2015 certified company offers over 9,000 ELISA kit options for 16 species, more than 13,000 monoclonal and polyclonal primary antibodies, and proteins with greater than 95% purity. Products serve various research applications including cell function assays, cytokine detection, and COVID-19 research.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
InVivo BioTech Services GmbH
Germany · 2 relevant products
BiosPacific
United States · 1 relevant product
Meridian Bioscience - Life Science Divis
United States · 2 relevant products
81 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 116 closest product alternatives
InVivo BioTech Services GmbH · Germany
SARS-CoV-2 antigens for use in diagnostic immunoassay development and COVID-19 testing platforms. These recombinant antigens enable rapid antibody discovery, assay optimization, and clinical diagnostic kit production. Manufactured under GMP-aligned standards for research, diagnostic, and preclinical applications.
BiosPacific · United States
Monoclonal antigens for SARS-CoV-2 antibody detection in COVID-19 diagnostics. Supports immunoassay development for COVID-19 infection testing.
Meridian Bioscience - Life Science Divis · United States
Novel antigens and antibodies for COVID-19 diagnostic assay development supplied during the pandemic response. These reagents support development of accurate SARS-CoV-2 detection assays.
113 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products